Symbol Name ID |
Gucy2c
guanylate cyclase 2c MGI:106903 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Gucy2ctm1Gar/Gucy2ctm1Gar B6.129S6-Gucy2ctm1Gar |
cardiac hypertrophy | J:178241 |
hepatic steatosis | J:178241 | |
impaired glucose tolerance | J:178241 | |
increased body weight | J:178241 | |
increased circulating insulin level | J:178241 | |
increased circulating leptin level | J:178241 | |
increased compensatory feeding amount | J:178241 | |
increased heart weight | J:178241 | |
increased liver triglyceride level | J:178241 | |
increased subcutaneous adipose tissue amount | J:178241 | |
increased total body fat amount | J:178241 | |
polyphagia | J:178241 | |
Gucy2ctm1Gar/Gucy2ctm1Gar either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6J) |
decreased susceptibility to bacterial infection | J:43046 |
decreased susceptibility to bacterial infection induced morbidity/mortality | J:43046 | |
diarrhea | J:43046 | |
Gucy2ctm1Gian/Gucy2ctm1Gian involves: 129P2/OlaHsd * Black Swiss |
decreased susceptibility to infection | J:43682 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|